Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug;61(8):883-886.
doi: 10.1097/DCR.0000000000001139.

Neoadjuvant Therapy for Rectal Cancer

Affiliations
Case Reports

Neoadjuvant Therapy for Rectal Cancer

Ira L Leeds et al. Dis Colon Rectum. 2018 Aug.

Abstract

A 63-year-old man presents to his primary care doctor with a one-month history of blood in his stools. He is referred for a colonoscopy and found to have a friable mass along the anterior wall just proximal to the second rectal fold. A biopsy confirms moderately-differentiated adenocarcinoma. The patient then obtains pelvic magnetic resonance imaging and chest, abdomen, and pelvis computed tomography demonstrating local invasion of the primary tumor into the mesorectal fat (T3), no suspicious regional lymph nodes (N0), and no evidence of distant metastatic disease (M0).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None

Figures

Figure 1
Figure 1
Neoadjuvant-eligible staging findings using pelvic magnetic resonance imaging. A) T3 midrectal lesion with posterior invasion through the muscularis propria (low intensity signal encircling rectum) into the mesorectal fat with arrows marking lateral extent. B) T2 mid-rectal, posterior lesion with thinning of the muscularis propria and a 5mm pathologic lymph node (arrow) located in the posterior mesorectal fat.
Figure 2
Figure 2
Evaluation and treatment algorithm for neoadjuvant-eligible rectal cancer.

References

    1. Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987. - PubMed
    1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Dutch Colorectal Cancer Group Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646. - PubMed
    1. Monson JRT, Weiser MR, Buie WD, et al. Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised) Dis Colon Rectum. 2013;56:535–550. - PubMed
    1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology - Rectal Cancer (Ver 3.2017) 2017 Available from: https://www.nccn.org/professionals/physician_gls/pdf/rectal_blocks.pdf. Accessed December 21, 2017.
    1. Nougaret S, Rouanet P, Molinari N, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology. 2012;263:409–418. - PubMed

Publication types

MeSH terms